Dinalbuphine sebacate
- Generic Name
- Dinalbuphine sebacate
- Drug Type
- Small Molecule
- Chemical Formula
- C52H68N2O10
- CAS Number
- 311768-81-7
- Unique Ingredient Identifier
- 464OXX39Y6
- Background
Dinalbuphine sebacate is under investigation in clinical trial NCT02468128 (A Study of Intramuscular Sebacoyl Dinalbuphine Ester for Post-Hemorrhoidectomy Pain Management).
Postoperative Pain Management on Patients Undergoing Lung Tumor Resection
Not yet recruiting
- Conditions
- Postoperative PainLung TumorLung Cancer
- Interventions
- First Posted Date
- 2024-05-03
- Last Posted Date
- 2024-05-03
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 400
- Registration Number
- NCT06397807
A Novel, Potent and Non-addictive Analgesic of Combinations for Knee Replacement Moderate to Severe Pain Management
Phase 2
- Conditions
- Pain, Postoperative
- Interventions
- First Posted Date
- 2023-05-06
- Last Posted Date
- 2023-07-27
- Lead Sponsor
- Sinew Pharma Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT05842733
- Locations
- 🇨🇳
Taipei Veterans General Hospital, Taipei City, Beitou District, Taiwan
Postoperative Pain Management on Uvulopalatopharyngoplasty Patients
Phase 4
Not yet recruiting
- Conditions
- Obstructive Sleep Apnea-hypopnea SyndromePain, PostoperativePain, Acute
- Interventions
- Other: Routine practice
- First Posted Date
- 2023-04-24
- Last Posted Date
- 2023-04-25
- Lead Sponsor
- Li-Jen Hsin
- Target Recruit Count
- 78
- Registration Number
- NCT05825495
Naldebain® Extended-release Injection After Cesarean Section in Pain Management
- Conditions
- Post Operative PainCaesarean SectionAnalgesia
- Interventions
- First Posted Date
- 2022-07-06
- Last Posted Date
- 2022-07-06
- Lead Sponsor
- Tri-Service General Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT05446311
Postoperative Pain Management of Caesarean Section
Recruiting
- Conditions
- Postoperative PainCaesarean SectionAnalgesia
- Interventions
- Drug: Intravenous patient-control analgesia
- First Posted Date
- 2021-08-18
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- Mackay Memorial Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT05009771
- Locations
- 🇨🇳
MacKay Memorial Hospital, Taipei, Taiwan
🇨🇳MacKay Memorial Hospital Tamsui Branch, New Taipei City, Taiwan
Naldebain for Pain Management of Laparoscopic Cholecystectomy
Phase 2
Completed
- Conditions
- Pain, PostoperativePain, ChronicCholecystitisQuality of Life
- Interventions
- Drug: Placebo solution
- First Posted Date
- 2021-03-22
- Last Posted Date
- 2022-04-20
- Lead Sponsor
- E-DA Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT04808544
- Locations
- 🇨🇳
E-Da Hospital, Yanchao, Kaohsiung, Taiwan
Naldebain for Pain Control After Bariatric Surgery
Phase 2
- Conditions
- Pain, PostoperativePain, ChronicBariatric SurgeryObesityPharmacokinetics
- Interventions
- Drug: Placebo solution
- First Posted Date
- 2020-12-03
- Last Posted Date
- 2021-12-28
- Lead Sponsor
- E-DA Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT04651361
- Locations
- 🇨🇳
E-Da Hospital, Yanchao, Kaohsiung, Taiwan
A Bioavailability Study of NALDEBAIN ER Injection and Nalbuphine Injection in Healthy Volunteers.
- First Posted Date
- 2020-02-05
- Last Posted Date
- 2021-11-19
- Lead Sponsor
- Lumosa Therapeutics Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT04256434
- Locations
- 🇺🇸
WCCT Global Inc., Cypress, California, United States
NALDEBAIN for Postoperative Pain Management in Take Down of Anastomosis
- First Posted Date
- 2019-02-26
- Last Posted Date
- 2019-02-26
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT03854851
- Locations
- 🇨🇳
China Medical University & Hospital, Taichung, Taiwan
Comparison of the Efficacy and Safety of NALDEBAIN With Conventional Treatment After Laparoscopic Cholecystectomy
- First Posted Date
- 2018-10-19
- Last Posted Date
- 2020-07-16
- Lead Sponsor
- Cathay General Hospital
- Target Recruit Count
- 44
- Registration Number
- NCT03713216
- Locations
- 🇨🇳
Cathay General Hospital, Taipei, Taiwan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath